Nanoparticles Target Tumor Scarring to Restore Immune Response in Mice
New research shows targeted nanoparticles can reduce scar tissue in liver and lung cancers, enabling immune cells to respond to therapy in mice. The findings suggest potential for improved immunotherapy outcomes in patients with chronic disease-related cancers.
